Neuropsychopharmacology
- Effects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit1 year ago
- Selective KOR antagonist alters functional patch sizes in individualized brain system: results from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)1 year ago
- Identifying brain-penetrant small-molecule modulators of human microglia using a cellular model of synaptic pruning1 year ago
- Demand for heroin in rats: effects of non-drug alternative substitutes and complements1 year ago
- Posttraining noradrenergic stimulation maintains hippocampal engram reactivation and episodic-like specificity of remote memory1 year ago
- Antipsychotics cause reversible structural brain changes within one week1 year ago
- Multi-ancestry genome-wide association meta-analysis of buprenorphine treatment response1 year ago
Journal of Psychopharmacology
- Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants2 years ago
- Psychedelics and the ‘inner healer’: Myth or mechanism?2 years ago
- Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review2 years ago
- Just a gut feeling: Faecal microbiota transplant for treatment of depression – A mini-review2 years ago
- Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder2 years ago
- Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression2 years ago
- The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients2 years ago
European Neuropsychopharmacology
- Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents2 years ago
- Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials2 years ago
- Schizophrenia patients are not benefiting from worldwide improvements in life expectancy2 years ago
- Cognitive screening in bipolar disorder2 years ago
- Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions2 years ago
- Pre-existing chronic physical morbidity and excess mortality in people with bipolar disorder: A population-based cohort study in 2008–20182 years ago
- The role of anxiety and insomnia in the relationship between COVID-19 perseverative cognition and depression: Parallel and serial mediation analyses2 years ago